Darifenacin Tablet, Extended Release
Product Images NDC 62332-224

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Darifenacin (NDC 62332-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Darifenacin 15 mg

This is a description of a medicine tablet. The tablet contains 17858 mg of arfbnecn-NG 62332-224-30 ctomide loprole 13 dfenacn B&o. The usual dosage is one tablet per day. The tablet has to be stored at 25°C (77°F) and excursions are permitted. The tablet is an extended-release type and measures 28x30mm. It is not to be taken by people who are not prescribed by the doctor as it is a prescription medicine. The manufacturer is Alembic Pharmaceuticals Limited. The address of the manufacturer is given below.*

FDA Label Image

Darifenacin 2a

FDA Label Image

Darifenacin 2b

FDA Label Image

Darifenacin 2c

FDA Label Image

Darifenacin 7 5 mg

Each tablet contains 8929 mg of Darifenacin and provides 75 mg of Darifenacin. The recommended dosage is one tablet daily. Darifenacin is an extended-release medication. Not available.*

FDA Label Image

Figure 1 (Darifenacin Figure1)

This text is a table showing the mean plasma concentration of Darifenacin in ng/mL over a 24-hour period at different time points post-dose. The concentrations were measured in a group of individuals, including 95 EMs and 6 PMs for a 7.5mg dose and 104 EMs and 10 PMs for a 15mg dose.*

FDA Label Image

Darifenacin Structure

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.